Gastrointestinal Permeability in Cancer Patients
Author Information
Author(s): Melichar Bohuslav, Hyšpler Radomír, Dragounová Emanuela, Dvořák Josef, Kalábová Hana, Tichá Alena
Primary Institution: Charles University Medical School & Teaching Hospital
Hypothesis
What is the effect of paclitaxel and platinum chemotherapy on intestinal permeability in ovarian and breast cancer patients?
Conclusion
The study found that increased lactulose absorption and certain ratios were linked to serious toxicity in patients treated with paclitaxel and platinum.
Supporting Evidence
- Patients with serious toxicity had lower baseline absorption of certain sugars.
- Increased lactulose/mannitol ratio predicted serious toxicity.
- The study included both chemotherapy-naïve and previously treated patients.
Takeaway
This study looked at how chemotherapy affects the gut in women with breast and ovarian cancer. It found that some changes in gut function can predict if patients will have serious side effects.
Methodology
Intestinal permeability was assessed by measuring urinary sucrose, lactulose, xylose, and mannitol after an oral challenge.
Potential Biases
Potential bias due to the observational nature of the study and the small number of patients.
Limitations
The study had a limited sample size and did not distinguish between types of toxicity.
Participant Demographics
36 women, mean age 57 years, with ovarian cancer, breast cancer, and unknown primary carcinoma.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website